D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 98 Citations 52,730 638 World Ranking 4096 National Ranking 2318

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

His main research concerns Multiple myeloma, Internal medicine, Surgery, Bortezomib and Oncology. His Multiple myeloma study improves the overall literature in Immunology. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine.

His study in Surgery is interdisciplinary in nature, drawing from both Placebo and Immunopathology. Sagar Lonial has researched Bortezomib in several fields, including Proteasome inhibitor and Tolerability. His studies in Oncology integrate themes in fields like Cancer, Treatment options, Maintenance therapy and Lymphoma.

His most cited work include:

  • Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
  • Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
  • Bortezomib or high-dose dexamethasone for relapsed multiple myeloma (2128 citations)

What are the main themes of his work throughout his whole career to date?

Sagar Lonial mainly investigates Internal medicine, Multiple myeloma, Oncology, Bortezomib and Lenalidomide. His Internal medicine study incorporates themes from Gastroenterology, Surgery and Immunology. His work deals with themes such as Cancer research, Adverse effect, Pharmacology and Dexamethasone, which intersect with Multiple myeloma.

His research integrates issues of Relapsed refractory, Refractory, Clinical trial and Refractory Multiple Myeloma in his study of Oncology. His Bortezomib study combines topics from a wide range of disciplines, such as Proteasome inhibitor, Progressive disease, Combination therapy and Phases of clinical research. His work carried out in the field of Lenalidomide brings together such families of science as Regimen, Tolerability and Neutropenia.

He most often published in these fields:

  • Internal medicine (57.24%)
  • Multiple myeloma (55.37%)
  • Oncology (33.88%)

What were the highlights of his more recent work (between 2018-2021)?

  • Multiple myeloma (55.37%)
  • Internal medicine (57.24%)
  • Oncology (33.88%)

In recent papers he was focusing on the following fields of study:

Sagar Lonial mostly deals with Multiple myeloma, Internal medicine, Oncology, Cancer research and Dexamethasone. In his research on the topic of Multiple myeloma, Survival rate is strongly related with Progression-free survival. His study in Lenalidomide, Refractory, Adverse effect, Daratumumab and Bortezomib falls under the purview of Internal medicine.

In his study, which falls under the umbrella issue of Lenalidomide, Hazard ratio and Gastroenterology is strongly linked to Regimen. In the subject of general Oncology, his work in Overall survival is often linked to In patient, thereby combining diverse domains of study. His research integrates issues of Cisplatin, Cancer cell, Transcription factor, CD38 and Kinase in his study of Cancer research.

Between 2018 and 2021, his most popular works were:

  • Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study. (129 citations)
  • A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis (125 citations)
  • International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders (91 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Multiple myeloma, Internal medicine, Oncology, Lenalidomide and Dexamethasone are his primary areas of study. His Multiple myeloma research is multidisciplinary, relying on both Cancer research and Clinical trial. His research in Refractory, Bortezomib, Adverse effect, Regimen and Survival rate are components of Internal medicine.

His studies in Adverse effect integrate themes in fields like Nausea, Proteasome inhibitor and Gastroenterology. His research in Oncology intersects with topics in MEDLINE, Standard of care, Elotuzumab, Proportional hazards model and Transplantation. His work in Lenalidomide tackles topics such as Interim analysis which are related to areas like Pembrolizumab.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham.
Autophagy (2012)

7068 Citations

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

6803 Citations

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Autophagy (2016)

4781 Citations

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

Paul G. Richardson;Pieter Sonneveld;Michael W. Schuster;David Irwin.
The New England Journal of Medicine (2005)

2881 Citations

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)

2775 Citations

Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America

Donna M. Weber;Christine Chen;Ruben Niesvizky;Michael Wang.
The New England Journal of Medicine (2007)

1481 Citations

Initial genome sequencing and analysis of multiple myeloma

Michael A. Chapman;Michael S. Lawrence;Jonathan J. Keats;Kristian Cibulskis.
Nature (2011)

1338 Citations

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo.
The New England Journal of Medicine (2015)

1148 Citations

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

Antonio Palumbo;Hervé Avet-Loiseau;Stefania Oliva;Henk M. Lokhorst.
Journal of Clinical Oncology (2015)

1144 Citations

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie.
Lancet Oncology (2016)

1131 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sagar Lonial

Paul G. Richardson

Paul G. Richardson

Harvard University

Publications: 323

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 316

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 287

Meletios A. Dimopoulos

Meletios A. Dimopoulos

National and Kapodistrian University of Athens

Publications: 272

Philippe Moreau

Philippe Moreau

University of Nantes

Publications: 224

Nikhil C. Munshi

Nikhil C. Munshi

Harvard University

Publications: 222

Antonio Palumbo

Antonio Palumbo

University of Turin

Publications: 201

Angela Dispenzieri

Angela Dispenzieri

Mayo Clinic

Publications: 201

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 194

Morie A. Gertz

Morie A. Gertz

Mayo Clinic

Publications: 193

Pieter Sonneveld

Pieter Sonneveld

Erasmus University Rotterdam

Publications: 174

Gareth J. Morgan

Gareth J. Morgan

New York University

Publications: 160

Evangelos Terpos

Evangelos Terpos

National and Kapodistrian University of Athens

Publications: 159

Hartmut Goldschmidt

Hartmut Goldschmidt

University Hospital Heidelberg

Publications: 159

Michele Cavo

Michele Cavo

University of Bologna

Publications: 155

Maria-Victoria Mateos

Maria-Victoria Mateos

University of Salamanca

Publications: 152

Trending Scientists

Abdenour Hadid

Abdenour Hadid

University of Oulu

Reinaldo Morabito

Reinaldo Morabito

Federal University of São Carlos

Geir B. Asheim

Geir B. Asheim

University of Oslo

Chung-Che Chou

Chung-Che Chou

National Taiwan University

Carlos Moreno-Castilla

Carlos Moreno-Castilla

University of Granada

John E. Straub

John E. Straub

Boston University

Hazime Saitô

Hazime Saitô

National Cancer Research Institute, UK

Chaobin He

Chaobin He

National University of Singapore

Penelope Morgan

Penelope Morgan

University of Idaho

Hee-Mock Oh

Hee-Mock Oh

Korea Research Institute of Bioscience and Biotechnology

Christopher B. Eckman

Christopher B. Eckman

Mayo Clinic

Yujie Wang

Yujie Wang

University of Maryland, Baltimore County

T. N. Krishnamurti

T. N. Krishnamurti

Florida State University

Myron Essex

Myron Essex

Harvard University

Marco Bertamini

Marco Bertamini

University of Liverpool

Jae K. Oh

Jae K. Oh

Mayo Clinic

Something went wrong. Please try again later.